Mezavant

Mesalazine, the active ingredient in Mezavant, is a 5‑ASA (5‑aminosalicylic acid) presented as a tablet for oral use. It is employed in the management of inflammatory bowel disease, particularly ulcerative colitis, in adult patients. GNH USA supplies Mezavant as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Mezavant as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Mezavant is an oral 5‑ASA formulation that targets the inflammatory pathway of the colon.

- Ulcerative colitis: reduces inflammation and helps maintain remission remission. - Crohn's disease affecting the colon: assists  as     ...

Common  ...

...

...